Jeff Borghoff

Patient Advisor

In March of 2016, at the age of 51, Jeff Borghoff was diagnosed with Younger Onset/Early-Stage Alzheimer’s Disease. Since Jeff’s diagnosis, he has worked with the national Alzheimer’s Association as a member of the National Early-Stage Advisory Group and currently serves on the board of directors for the Alzheimer’s Association Greater NJ chapter.  Jeff also serves as an Alzheimer’s Congressional Team member and NJ State Advocacy Champion for Alzheimer’s Disease and Related Dementia legislative policies.  Jeff is a clinical trial participant in the Biogen Aducanumab research study.